Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 158,559 | 119,849 | 125,860 | 108,651 | 99,102 |
| Cost of Goods | 81,157 | 57,195 | 66,158 | 50,114 | 48,657 |
| Gross Profit | 77,402 | 62,654 | 59,702 | 58,537 | 50,445 |
| Operating Expenses | 42,031 | 37,466 | 41,854 | 37,957 | 41,409 |
| Operating Income | 35,528 | 25,383 | 18,006 | 20,694 | 9,693 |
| Interest Expense | 77 | 53 | 11 | 16 | 59 |
| Other Income | -1,749 | 337 | -255 | 324 | 175 |
| Pre-tax Income | 33,702 | 25,667 | 17,740 | 21,002 | 9,809 |
| Income Tax | 11,772 | 8,486 | 5,214 | 7,144 | -2,594 |
| Net Income Continuous | 21,930 | 17,181 | 12,526 | 13,858 | 12,403 |
| Minority Interests | N/A | -39 | -24 | 5 | -19 |
| Net Income | $21,872 | $17,220 | $12,550 | $13,853 | $12,422 |
| EPS Basic Total Ops | 0.33 | 0.27 | 0.20 | 0.22 | 0.20 |
| EPS Basic Continuous Ops | 0.34 | 0.27 | 0.20 | 0.22 | 0.20 |
| EPS Diluted Total Ops | 0.31 | 0.26 | 0.19 | 0.21 | 0.19 |
| EPS Diluted Continuous Ops | 0.32 | 0.26 | 0.19 | 0.21 | 0.19 |
| EBITDA(a) | $39,952 | $29,403 | $23,564 | $25,513 | $15,178 |